ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Research Program Announcement

February 13, 1981

Gavel Changes Hands At NCAB, Korn advises New Members On Role

February 8, 1991

Senate confirms Crawford as FDA commissioner.

July 22, 2005

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

NCA To Hear Centers’ Reaction, Other Subcommittee, Scientific Reports

November 11, 1977

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983